News From Industry Sources
FDA approves SOMA(R) (carisoprodol) 250 mg
September 17, 2007
The Food and Drug Administration has approved SOMAŽ (carisoprodol) 250 mg as a new recommended dose of SOMA for the relief of discomfort associated with acute, painful musculoskeletal conditions, such as backache. Story
Study shows Medtronic neurostimulation therapy improves chronic neuropathic leg and back pain
September 14, 2007
A major study published online today by the international medical journal PAIN and supported by Medtronic, Inc. found that people with chronic neuropathic leg and back pain benefited significantly more from neurostimulation therapy plus conventional medical management than from conventional medical management alone. Story
|